Compare DexCom, Inc. (DXCM) vs Ford Motor Company (F) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Ford Motor Company — how do they compare? DexCom, Inc. trades at $84.14 (market cap $31.86B), while Ford Motor Company trades at $12.17 (market cap $48.85B). The key difference: Ford Motor Company is the larger of the two by market cap, and Ford Motor Company pays a 4.9% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Ford Motor Company for 105 Days on average.
| DXCM | F | |
|---|---|---|
Market Cap | $31.86B | $48.85B |
Volume | 3,607,070 | 57,748,965 |
Sector | Health | Consumer Cyclical |
52-Week High | $92.34 | $17.44 |
52-Week Low | $54.84 | $11.21 |
Typical Hold Time | 62 Days | 105 Days |
Enterprise Value | $31.32B | $180.81B |
Dividend Yield | — | 4.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.11, down 0.23% on the day, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $0.70, beating expectations, and has shown consistent revenue growth, with 2025 revenue reaching $4.66 billion and net income of $836.3 million. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target. Recent news highlights growth opportunities in Type 2 diabetes care and key executive promotions.
The outlook for DXCM is positive due to robust earnings beats, expanding market opportunities, and strong institutional support. However, risks include competitive pressures, reimbursement challenges, and a high valuation with a P/E of 33.38. The stock presents a growth opportunity but requires monitoring of execution against these risks.
Ford Motor Company (F) trades at $12.17, up 0.37% with a bearish technical outlook despite recent earnings beats. The company shows mixed fundamentals with $187.27B revenue but negative net income margin of -3.93% and concerning debt-to-asset ratio of 56.49%. Recent news highlights sales declines and production challenges, though the company maintains strong cash flow from operations of $21.28B. Analyst consensus remains cautiously optimistic with a $15.90 price target despite near-term headwinds.
Ford faces significant execution risks amid declining sales and competitive pressures, but valuation metrics appear attractive with P/E of 11.21 and P/S of 0.26. The hybrid vehicle transition and strong commercial division provide potential upside, though investors must weigh debt levels and margin pressures against the discounted valuation and analyst price target suggesting 30% upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Ford Motor Company
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →
